Skip to content

Study of Cardiac MRI in Patients With Left-Sided Breast Cancer Receiving Radiation Therapy

Prospective Pilot Study of Early Markers of Radiation-Induced Cardiac Injury in Patients With Left-Sided Breast Cancer Receiving Photon or Proton Therapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02199366
Enrollment
24
Registered
2014-07-24
Start date
2014-09-30
Completion date
2025-03-31
Last updated
2025-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Cardiac MRI, Radiation, Proton Radiation, Breast Cancer

Brief summary

This is a pilot study to determine if there are changes in heart function following completion of radiation therapy for breast cancer as measured by cardiac magnetic resonance imaging (cardiac MRI) scans. Additional purposes of this study are to assess cardiac side effects from radiation treatment, evaluate cardiac MRI changes by radiation technique, and compare quality of life questionnaires.

Detailed description

As part of this study, participants will have a cardiac MRI at baseline and a follow-up cardiac MRI within 1 year after completion of standard radiation therapy for left-sided breast cancer. The cardiac MRI scans will be evaluated to determine if there are changes in cardiac function within 1 year after radiation treatment. Patients will be asked to complete a questionnaire before and after treatment that asks about their health and any symptoms they may be having. Physical exams and any other standard of care service or treatment will be at the discretion of the treating physician.

Interventions

PROCEDURECardiac magnetic resonance (cardiac MRI)

Participants will have a cardiac MRI at baseline and within 1 year after completion of radiation therapy.

Sponsors

Ocala Royal Dames
CollaboratorUNKNOWN
University of Florida
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Left-sided breast cancer stage I-III. * Indications for adjuvant regional nodal and breast or chest wall radiation therapy (RT). * Women and men are allowed. * Must be at least 18 years old at time of consent.

Exclusion criteria

* Pregnant and/or breastfeeding women or patients of child-producing potential not willing to use contraception while on study. * Prior history of cardiovascular disease per physician discretion. * Stage 0 and IV breast cancer. * Prior radiation therapy to chest. * Concurrent trastuzumab per physician discretion.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants with changes in cardiac function.1 year after completion of radiation therapyA change in cardiac function may include shifts from baseline measures of LV mass, strain, ejection fraction, and late gadolinium enhancement.

Secondary

MeasureTime frameDescription
Proportion of patients with serious cardiac side effects.1 year after completion of radiation therapyIncludes myocardial infarction, valve disorder, congestive heart failure, and angina.
Mean quality of life score.1 year after radiation treatmentComparison of baseline and post treatment quality of life questionnaires completed by participants.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026